investorscraft@gmail.com

Intrinsic Value of Owens & Minor, Inc. (OMI)

Previous Close$7.97
Intrinsic Value
Upside potential
Previous Close
$7.97

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Owens & Minor, Inc. operates as a global healthcare logistics company specializing in distribution, supply chain management, and clinical solutions. The company serves hospitals, integrated delivery networks, and other healthcare providers, offering medical-surgical products, pharmaceuticals, and supply chain technology. Its revenue model is driven by bulk distribution, direct-to-provider logistics, and value-added services such as inventory management and procurement optimization. Owens & Minor holds a strong position in the healthcare supply chain sector, leveraging its extensive distribution network and technological capabilities to differentiate itself from competitors. The company operates in a highly fragmented but essential industry, where efficiency and reliability are critical. Its market positioning is reinforced by long-term contracts with healthcare providers and manufacturers, providing stable revenue streams. However, the sector faces margin pressures due to regulatory changes and competitive pricing dynamics, requiring continuous operational improvements.

Revenue Profitability And Efficiency

Owens & Minor reported revenue of $10.7 billion for FY 2024, reflecting its scale in healthcare distribution. However, the company posted a net loss of $362.7 million, with diluted EPS of -$4.73, indicating profitability challenges. Operating cash flow stood at $161.5 million, while capital expenditures were $210.9 million, suggesting reinvestment needs. The negative net income highlights margin pressures in its core operations.

Earnings Power And Capital Efficiency

The company's earnings power is constrained by its net loss, though operating cash flow remains positive. Capital efficiency is under scrutiny given the high capital expenditures relative to cash flow. The negative EPS suggests limited earnings generation, likely due to cost inflation and competitive pricing in the healthcare logistics sector.

Balance Sheet And Financial Health

Owens & Minor's balance sheet shows $49.4 million in cash and equivalents against $2.14 billion in total debt, indicating a leveraged position. The high debt load raises concerns about financial flexibility, though the company's operating cash flow provides some liquidity. The absence of dividends aligns with its focus on debt management and operational stability.

Growth Trends And Dividend Policy

Growth trends are muted given the net loss, though revenue remains substantial. The company does not pay dividends, prioritizing debt reduction and operational investments. Future growth may depend on margin improvements and strategic initiatives in supply chain optimization.

Valuation And Market Expectations

The market likely views Owens & Minor cautiously due to its profitability challenges and high leverage. Valuation metrics would reflect its earnings deficit, though its revenue base and industry position may support long-term potential if operational improvements materialize.

Strategic Advantages And Outlook

Owens & Minor's strategic advantages include its extensive distribution network and healthcare sector expertise. The outlook hinges on cost management and leveraging technology to enhance margins. Regulatory and competitive pressures remain key risks, but the company's entrenched market position provides a foundation for recovery.

Sources

Company filings (10-K), financial statements

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount